MedAI Verdict
All comparisons

Implicity vs Triomics

Implicity answers to a device clinic and Triomics to a cancer program, so each has its own audience. Implicity's ILR ECG Analyzer reclassifies insertable cardiac monitor events. The vendor says it cuts false positives by 79% on Medtronic ILR recordings with 99% sensitivity. A Europace paper by Implicity authors covered 546 patients and 879 abnormal episodes and reported specificity of 76.0% and sensitivity of 98.6%. The homepage names no EHR, and the vendor says the platform can integrate with electronic health records.

Triomics adds pre-charting note drafts and registry abstraction to PRISM trial matching. The vendor says every registry field carries a citation, for NAACCR, SEER, COC and QOPI measures. Its homepage says four of ten top US cancer centers trust Triomics, and the vendor reports roughly 95% matching accuracy for PRISM from a 2024 npj Digital Medicine paper. Pricing runs through a demo request.

Decision support · Reviewed November 2, 2026

IM

Implicity

by Implicity · founded 2016

Cloud platform for remote monitoring of pacemakers and ICDs, with AI alert filtering and heart failure risk scoring for device clinics.

Triomics logo

Triomics

by triomics inc.

Oncology AI agents that match patients to clinical trials, prepare visits and curate cancer registries from notes, reports and faxes.

When to pick each one

Implicity

  • AI reclassification of insertable monitor events
  • ISO 13485 and ISO 27001 logos on its site
Read the full Implicity review

Triomics

  • Registry curation for NAACCR, SEER, COC and QOPI
  • Pre-charting note drafts for oncology visits
  • Demo, 30-minute working session, synthetic-data sandbox
Read the full Triomics review

Score

Each row shows points earned of points available under the published rubric.

Implicity

36of 100

Competitive

Triomics

12of 100

Tracked
Score by dimension for Implicity and Triomics
DimensionImplicityTriomicsDifference
FDA clearance12 / 120 / 12+12
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 5.62.8 / 5.6-2.8
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 4.83.4 / 4.8-3.4
Bidirectional write-back0 / 1.20 / 1.20
Peer-reviewed papers8.4 / 210 / 21+8.4
RCT / meta-analysis / systematic review0 / 90 / 90
Funding & adoption signal3 / 123 / 120
Pricing transparency1.3 / 2.51.3 / 2.50
Years in market6 / 60 / 6+6

Scroll horizontally to see every column.

How scores are computed

Pricing

Implicity

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Triomics

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. Demo request and synthetic-data sandbox offered.

Evidence

Implicity

FDA decisions

Peer-reviewed

1 PubMed record names Implicity.

Triomics

FDA decisions

No FDA decision cited in our research as of November 2, 2026.

Compliance and integrations

Documented from each vendor’s own pages.

SpecImplicityTriomics
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot specifiedEpic, OncoEMR, iKnowMed, Cerner
Founded2016n/a
HQFRUS

Scroll horizontally to see both columns.

Common questions

Open the full decision support comparison

Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.